IL1B and neoplasm: After ingenol mebutate treatment in vivo (i) B16 tumour tissue show a ≈1.5 fold induction of IL-1β mRNA [21] and (ii) tumour treatment sites show a ≈2.5 fold increase in IL-1β protein levels (Fig 5B).